Journal of cosmetic dermatology · 2020
The 577-nm pro-yellow diode laser as a reliable and effective tool for facial telangiectasia.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Mohammed Essam-Elden M, Makki Mahmoud A, Solyman Zeinab S, Elsaie Mohamed L
Аннотация
BACKGROUND: Laser treatment of vascular skin conditions is very useful option yet remains to be a very challenging task.
AIMS: To evaluate the efficacy of 577-nm diode laser for treating facial telangiectasia.
PATIENTS AND METHODS: Thirty patients with facial telangiectasia were included in this prospective study. All participants received 3 sessions of a single-pass 577-nm diode laser. Sessions were delivered on a monthly basis, and digital photographic assessment was made at baseline and on follow-up 1 month after the last treatment.
RESULTS: At the final visit, there was a significant improvement (> 50%) reported in 21/30 (70%) patients while a poor response was reported in 2/30 (6.7%) patients. The skin phototype and site of the lesions significantly affected the result outcome (P < .05) while none of the patients' age, sex, or duration of facial telangiectasia significantly affected the treatment outcome (P > .05). Postinflammatory hyperpigmentation occurred in 2(6.7%) patients which resolved within 1.5 months.
CONCLUSION: Facial telangiectasia can be successfully treated with a 577-nm diode laser with minimal side effects.
AIMS: To evaluate the efficacy of 577-nm diode laser for treating facial telangiectasia.
PATIENTS AND METHODS: Thirty patients with facial telangiectasia were included in this prospective study. All participants received 3 sessions of a single-pass 577-nm diode laser. Sessions were delivered on a monthly basis, and digital photographic assessment was made at baseline and on follow-up 1 month after the last treatment.
RESULTS: At the final visit, there was a significant improvement (> 50%) reported in 21/30 (70%) patients while a poor response was reported in 2/30 (6.7%) patients. The skin phototype and site of the lesions significantly affected the result outcome (P < .05) while none of the patients' age, sex, or duration of facial telangiectasia significantly affected the treatment outcome (P > .05). Postinflammatory hyperpigmentation occurred in 2(6.7%) patients which resolved within 1.5 months.
CONCLUSION: Facial telangiectasia can be successfully treated with a 577-nm diode laser with minimal side effects.